Dr Oded SHOSEYOV
PhD - Investigação
Israel
Outro(s) autor(es)
: PhD Jasmine Seror1, PhD, Tal Amzel1, MSc, Abraham Nyska2, DVM Dipl. ECVP, Revital Zarka1 , PhD, Revital Mandil-Levin1 , PhD, Nadav Orr1, PhD 1CollPlant Ltd., Ness-Ziona, Israel; 2 Sackler School of Medicine, University of Tel Aviv, Israel, 3The Robert
Objectives: We demonstrate tissue growth in subcutaneous injection of plant derived rhCollagen gel in rat model. Cell proliferation and angiogenesis was evident within the injected gel committed which coincided with natural sustained release of growth factors including vasculo-endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in a course of up to 45 days. We have tested different rhCollagen/HA formulations that displayed constant and low injection force even when injected via 32G needle, indicating ease of use for accurate deployment of the gel at selected sites.
Introduction: Hyaluronic acid have proved itself as a good dermal filler. However, its limited ability to promote cell proliferation and angiogenesis result in limited tissue integration which may cause face distortion, particularly in extreme face expressions. Collagen comprises the major component of connective tissues. However tissue extracted collagen suffer from many disadvantages, including inconsistency immunogenicity and risk of disease transmission. We are producing clinically tested human recombinant collagen in tobacco plants.
Materials / method: Plant derived rhCollagen was fibrillated and cross-linked by carbodiimide. Female Sprague Dawley rats were injected with 0.5 ml of rhCollagen gel at the dorsal plane of the rat’s back. Animals were sacrificed at time-points 1, 7, 14, 21, 30 and 45 days post-treatment and implants were assessed by histopathology and PDGF and VEGF content by ELISA. rhCollagen/HA formulations were prepared and injection force was tested by injection via 32G needle
Results: We demonstrate tissue growth in subcutaneous injection of plant derived rhCollagen gel in rat model. Cell proliferation and angiogenesis was evident within the injected gel which coincided with natural sustained release of growth factors including vasculo-endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in a course of up to 45 days. We have tested different rhCollagen/HA formulations that displayed constant and low injection force even when injected via 32G needle, indicating ease of use for accurate deployment of the gel at selected sites.
Conclusion: Plant derived rhCollagen promote tissue regeneration and holds great potential to augment the performance of HA derived dermal fillers by promoting tissue integration. Furthermore, rhCollagen maybe used as a matrix for PRP as already have been proven clinically and possibly for stem cells from different source in tissue augmentation.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Sim
Por favor indique a entidade (pessoa ou empresa): The research was funded by CollPlant Ltd which manufacture and sell plant derived rhCollagen
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Sim
Por favor indique a entidade (pessoa ou empresa): Yes, I am a consultant to the company
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Sim
Por favor indique a entidade (pessoa ou empresa): I am the CSO of the company as well as share holder
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Sim
Por favor informe a data...: Some are issued patents and some are still pending
e o status: Yes. CollPlant filed several patents in the field of rhCollagen
Este trabalho foi realizado com o patrocínio de: CollPlant Ltd